6420 Abrams
Ville Saint Laurent
Montreal, QC H4S 1Y2
Canada
514 331 7440
https://www.intelgenx.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Dwight Gorham | Chief Executive Officer | 315.43k | N/A | 1958 |
Mr. André Godin C.A., CPA, CA, CPA | President & CFO | 357.93k | N/A | 1964 |
Mr. Tommy Kenny J.D., L.L.B., M.Sc. | Senior VP & General Counsel | 208.79k | N/A | 1987 |
Ms. Nadine Paiement M.Sc. | Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp | 214.1k | N/A | 1977 |
Ms. Karen Kalayajian CPA | Vice President of Finance & Administration | N/A | N/A | 1980 |
Stephen Kilmer | Investor Relations Officer | N/A | N/A | N/A |
Ms. Ingrid Zerbe | Corporate Secretary | N/A | N/A | 1954 |
Zenoz Nina Pourhassan | VP of Quality Operations of Subsidiary | N/A | N/A | N/A |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
IntelGenx Technologies Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.